These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 36923530)
1. The delta subunit of the GABA Li N; Xu X; Liu D; Gao J; Gao Y; Wu X; Sheng H; Li Q; Mi J Theranostics; 2023; 13(4):1355-1369. PubMed ID: 36923530 [No Abstract] [Full Text] [Related]
2. Glutamic Pyruvate Transaminase GPT2 Promotes Tumorigenesis of Breast Cancer Cells by Activating Sonic Hedgehog Signaling. Cao Y; Lin SH; Wang Y; Chin YE; Kang L; Mi J Theranostics; 2017; 7(12):3021-3033. PubMed ID: 28839461 [TBL] [Abstract][Full Text] [Related]
3. System analysis based on glutamine catabolic-related enzymes identifies GPT2 as a novel immunotherapy target for lung adenocarcinoma. Wang B; Pei J; Xu S; Liu J; Yu J Comput Biol Med; 2023 Oct; 165():107415. PubMed ID: 37657356 [TBL] [Abstract][Full Text] [Related]
4. Exosomal GPT2 derived from triple-negative breast cancer cells promotes metastasis by activating BTRC. Cui M; Peng J; Zhou Y; Wang X; Cui D Thorac Cancer; 2023 Jul; 14(21):2018-2025. PubMed ID: 37287397 [TBL] [Abstract][Full Text] [Related]
5. GPT2 Is Induced by Hypoxia-Inducible Factor (HIF)-2 and Promotes Glioblastoma Growth. Zhang B; Chen Y; Bao L; Luo W Cells; 2022 Aug; 11(16):. PubMed ID: 36010673 [TBL] [Abstract][Full Text] [Related]
6. Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy. Mitra D; Vega-Rubin-de-Celis S; Royla N; Bernhardt S; Wilhelm H; Tarade N; Poschet G; Buettner M; Binenbaum I; Borgoni S; Vetter M; Kantelhardt EJ; Thomssen C; Chatziioannou A; Hell R; Kempa S; Müller-Decker K; Wiemann S Int J Cancer; 2021 Apr; 148(8):1993-2009. PubMed ID: 33368291 [TBL] [Abstract][Full Text] [Related]
7. Loss of function mutation in glutamic pyruvate transaminase 2 (GPT2) causes developmental encephalopathy. Celis K; Shuldiner S; Haverfield EV; Cappell J; Yang R; Gong DW; Chung WK J Inherit Metab Dis; 2015 Sep; 38(5):941-8. PubMed ID: 25758935 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial enzyme GPT2 regulates metabolic mechanisms required for neuron growth and motor function in vivo. Baytas O; Davidson SM; DeBerardinis RJ; Morrow EM Hum Mol Genet; 2022 Feb; 31(4):587-603. PubMed ID: 34519342 [TBL] [Abstract][Full Text] [Related]
9. Mutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive features. Ouyang Q; Nakayama T; Baytas O; Davidson SM; Yang C; Schmidt M; Lizarraga SB; Mishra S; Ei-Quessny M; Niaz S; Gul Butt M; Imran Murtaza S; Javed A; Chaudhry HR; Vaughan DJ; Hill RS; Partlow JN; Yoo SY; Lam AT; Nasir R; Al-Saffar M; Barkovich AJ; Schwede M; Nagpal S; Rajab A; DeBerardinis RJ; Housman DE; Mochida GH; Morrow EM Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5598-607. PubMed ID: 27601654 [TBL] [Abstract][Full Text] [Related]
10. Activation of TMEM16A Ca Luo S; Wang H; Bai L; Chen Y; Chen S; Gao K; Wang H; Wu S; Song H; Ma K; Liu M; Yao F; Fang Y; Xiao Q J Adv Res; 2021 Nov; 33():253-264. PubMed ID: 34603794 [TBL] [Abstract][Full Text] [Related]
12. Loss of ABAT-Mediated GABAergic System Promotes Basal-Like Breast Cancer Progression by Activating Ca Chen X; Cao Q; Liao R; Wu X; Xun S; Huang J; Dong C Theranostics; 2019; 9(1):34-47. PubMed ID: 30662552 [TBL] [Abstract][Full Text] [Related]
13. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis. Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462 [TBL] [Abstract][Full Text] [Related]
14. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis. Zuo Y; Ulu A; Chang JT; Frost JA Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144 [TBL] [Abstract][Full Text] [Related]
15. GABAergic signaling facilitates breast cancer metastasis by promoting ERK1/2-dependent phosphorylation. Zhang D; Li X; Yao Z; Wei C; Ning N; Li J Cancer Lett; 2014 Jun; 348(1-2):100-8. PubMed ID: 24657659 [TBL] [Abstract][Full Text] [Related]
16. PIK3CA mutation affects the proliferation of colorectal cancer cells through the PI3K-MEK/PDK1-GPT2 pathway. Chen W; Dai G; Qian Y; Wen L; He X; Liu H; Gao Y; Tang X; Dong B Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34751411 [TBL] [Abstract][Full Text] [Related]
17. SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner. Wu J; Miao C; Wang Y; Wang S; Wang Z; Liu Y; Wang X; Wang Z J Transl Med; 2022 Dec; 20(1):603. PubMed ID: 36527113 [TBL] [Abstract][Full Text] [Related]
18. Loss of mitochondrial enzyme GPT2 causes early neurodegeneration in locus coeruleus. Baytas O; Kauer JA; Morrow EM Neurobiol Dis; 2022 Oct; 173():105831. PubMed ID: 35908744 [TBL] [Abstract][Full Text] [Related]
19. Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression. Song ZB; Ni JS; Wu P; Bao YL; Liu T; Li M; Fan C; Zhang WJ; Sun LG; Huang YX; Li YX Cell Death Dis; 2015 Mar; 6(3):e1703. PubMed ID: 25811800 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor‑κB signaling pathway. Yang L; Hong Q; Xu SG; Kuang XY; Di GH; Liu GY; Wu J; Shao ZM; Yu SJ Mol Med Rep; 2019 Nov; 20(5):4045-4258. PubMed ID: 31485630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]